Recombinant Staphylococcus saprophyticus subsp. saprophyticus ATP synthase subunit a (atpB)

What is Staphylococcus saprophyticus ATP synthase subunit a (atpB)?

The ATP synthase subunit a (atpB) in S. saprophyticus is a membrane protein component of the F0 sector of ATP synthase, consisting of 242 amino acids. This protein plays a critical role in maintaining the proton gradient across the bacterial membrane and is essential for ATP synthesis. The recombinant form typically includes a His-tag for purification purposes and can be expressed in E. coli expression systems for research applications . Structurally, atpB contains multiple transmembrane domains that form a proton channel within the ATP synthase complex.

How is recombinant S. saprophyticus atpB protein typically expressed and purified?

Methodology for expression and purification of recombinant atpB:

• Vector selection: Use of pET-based expression vectors with N-terminal His-tag

• Expression system: Transformation into E. coli expression strains (typically BL21(DE3))

• Induction conditions:

  • IPTG concentration: 0.5-1.0 mM

  • Temperature: 18-25°C (reduced temperature improves solubility)

  • Duration: 4-16 hours

• Cell lysis:

  • Mechanical disruption (sonication or French press)

  • Buffer composition: Tris/PBS-based buffer with detergents (e.g., n-dodecyl β-D-maltoside)

• Purification:

  • Immobilized metal affinity chromatography (IMAC) using Ni-NTA resin

  • Optional secondary purification: Size exclusion chromatography

• Final preparation: Lyophilization in Tris/PBS-based buffer with 6% trehalose at pH 8.0

What are the optimal storage conditions for recombinant atpB protein?

For long-term stability of recombinant S. saprophyticus atpB:

• Primary storage: Store lyophilized protein at -20°C to -80°C

• Working aliquots: Store at 4°C for up to one week

• Reconstituted protein: Add glycerol (final concentration 5-50%) and aliquot for long-term storage at -20°C/-80°C

• Stability considerations: Avoid repeated freeze-thaw cycles as this can significantly reduce protein activity

• Buffer recommendations: Tris/PBS-based buffer with 6% trehalose at pH 8.0 provides optimal stability

How should recombinant atpB be reconstituted for experimental use?

Detailed reconstitution protocol:

• Initial preparation: Briefly centrifuge the vial containing lyophilized protein to bring contents to the bottom

• Reconstitution medium: Add deionized sterile water to achieve concentration of 0.1-1.0 mg/mL

• Solubilization: Gently pipette to dissolve completely, avoid vigorous shaking

• Glycerol addition: For long-term storage, add glycerol to a final concentration of 5-50%

• Aliquoting: Divide into single-use aliquots before freezing

• Quality control: Verify protein concentration using Bradford assay or BCA method

• Activity verification: Test ATP hydrolysis activity using a coupled enzyme assay

What functional assays can be used to verify the activity of recombinant atpB?

Several complementary approaches can be employed:

• ATP hydrolysis assays:

  • Coupled enzyme assay using ATP, pyruvate kinase, and lactate dehydrogenase

  • Measurement of inorganic phosphate release using malachite green

• Reconstitution in liposomes:

  • Preparation of proteoliposomes containing purified ATP synthase components

  • Measurement of ATP synthesis driven by artificial proton gradients

• Proton translocation assays:

  • Use of pH-sensitive fluorescent dyes (e.g., ACMA)

  • Monitoring fluorescence changes in response to ATP hydrolysis

What role does ATP synthase play in biofilm formation in Staphylococcus species?

Research on S. aureus ATP synthase provides insights that may be relevant to understanding S. saprophyticus atpB function:

• Biofilm persistence: ATP synthase mutants (particularly ΔatpA) in S. aureus show altered biofilm formation capabilities. This suggests a critical role for ATP synthase beyond energy production

• Immune modulation: S. aureus ATP synthase influences host immune responses during biofilm-associated infections:

  • ΔatpA mutants elicit heightened proinflammatory cytokine production by leukocytes

  • This leads to improved biofilm clearance in infection models

  • The effect is cell lysis-dependent, as inhibition of bacterial lysis prevents cytokine production

• Metabolic adaptation: ATP synthase enables metabolic flexibility during biofilm formation, allowing bacteria to adjust to low-oxygen environments and nutrient limitation

• Potential mechanisms: ATP synthase may influence biofilm formation through:

  • Maintenance of intracellular pH homeostasis

  • Regulation of energy-dependent processes essential for biofilm matrix production

  • Modulation of toxin and protease production

These findings suggest that targeting ATP synthase could be a strategy for biofilm control in staphylococcal infections.

How can mutations in atpB affect bacterial physiology and virulence?

Studies on ATP synthase mutations in staphylococcal species reveal:

• Energy metabolism: Mutations in atpB disrupt proton translocation, compromising ATP synthesis and affecting all energy-dependent processes

• Virulence factor expression: In S. aureus, ATP synthase mutants show:

  • Decreased toxin and protease production (as determined by LC-MS/MS)

  • Altered leukocyte survival during interactions with biofilms

• Intracellular acidification: Mutations in ATP synthase genes (like atpG in S. aureus) impair intracellular acidification, which is required for optimal activity of fermentative enzymes that generate energy when respiration is compromised

• Biofilm clearance: ATP synthase alpha subunit mutant (ΔatpA) biofilms in S. aureus elicit enhanced inflammatory responses, resulting in improved biofilm clearance in infection models

These findings suggest that atpB mutations could significantly impact bacterial adaptation and pathogenicity.

What experimental approaches can be used to study the interaction between atpB and host immune cells?

Several methodological approaches can be employed:

• Cell-based co-culture systems:

  • Bacterial-leukocyte co-culture experiments using recombinant atpB

  • Measurement of cytokine production (IL-12p70, TNF-α, IL-6) via ELISA or cytometric bead arrays

  • Assessment of leukocyte survival and activation markers

• Activity-based protein profiling (ABPP):

  • Use of desthiobiotin-ATP probes to target ATP-interacting proteins

  • Analysis of protein-protein interactions during host-pathogen dynamics

  • Identification of ATP-dependent processes in both bacterial and host cells

• Proteomic approaches:

  • Comparative proteomics to identify differentially expressed proteins in response to atpB

  • Mass spectrometry analysis of protein complexes involving atpB

  • Phosphoproteomics to identify signaling pathways activated in response to ATP synthase components

• In vivo infection models:

  • Mouse models to assess the impact of atpB mutations on immune cell recruitment and activation

  • Assessment of myeloid-derived suppressor cell (MDSC) and macrophage infiltration

  • Measurement of local and systemic inflammatory responses

• Microscale thermophoresis (MST):

  • Analysis of protein-peptide interactions between atpB and host defense peptides

  • Determination of binding affinities and cooperative binding mechanisms

These approaches provide complementary data on how atpB influences host-pathogen interactions.

How can recombinant atpB be used in the development of antimicrobial strategies?

Research suggests several potential applications:

• Vaccine development:

  • ATP synthase subunits as vaccine antigens due to their conservation and essential function

  • Assessment of protective immune responses targeting atpB in animal models

• Drug target identification:

  • Structure-based drug design targeting specific regions of atpB

  • High-throughput screening for small molecule inhibitors of ATP synthase function

  • Assessment of synergistic effects with existing antibiotics

• Biofilm disruption strategies:

  • Development of approaches to modulate atpB function to enhance biofilm clearance

  • Combination therapies targeting ATP synthase alongside conventional antibiotics

• Host immune response modulation:

  • Targeting atpB to enhance proinflammatory responses in biofilm infections

  • Development of immunomodulatory therapies based on understanding atpB-host interactions

• Diagnostic applications:

  • Use of recombinant atpB-specific antibodies for detection of staphylococcal infections

  • Development of rapid diagnostic tests based on ATP synthase detection

What challenges exist in expressing and purifying functional recombinant atpB?

Researchers face several technical challenges:

• Membrane protein expression issues:

  • Toxicity to expression host due to membrane insertion

  • Low expression yields common with membrane proteins

  • Protein misfolding and inclusion body formation

• Solubilization and stability:

  • Requirement for detergents that maintain protein structure

  • Finding optimal detergent/lipid conditions for functional activity

  • Protein aggregation during concentration steps

• Functional assessment:

  • Need for reconstitution in lipid environments for activity assays

  • Complexity of multi-subunit ATP synthase complex reconstitution

  • Requirement for specialized equipment for functional analysis

• Structural considerations:

  • Protein flexibility and conformational dynamics

  • Interactions with other ATP synthase subunits

  • Native lipid requirements for proper function